Select Page

Statement from the European Pain Federation on ibuprofen and COVID-19

The European Pain Federation EFIC is aware of the speculation concerning risks associated with the use of ibuprofen for the treatment of COVID-19 (coronavirus) symptoms such as fever. EFIC recommends following the advice of the World Health Organisation on this subject. Ibuprofen has some known negative side effects for certain patients, though we do not yet have evidence of additional risks associated with COVID-19. We will continue to monitor the situation and provide more information when it becomes available.

EFIC is organizing a task force to provide guidance on the issue. If you wish to be involved, please contact

Source: @WHO on Twitter